The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Educational Lecture

Educational Lecture 2-3F Tyrosine kinase inhibitor therapy discontinuation for chronic myelogenous leukemia to achieve clinical cure: current status and future perspectives

Sat. Oct 13, 2018 3:20 PM - 3:50 PM No.3 (Osaka International Convention Center, 12F Conference Hall)

Chair: Kazunori Onishi (Japanese Red Cross Tokai-Hokuriku Block Blood Center, Japan)

[EL2-3F] Tyrosine kinase inhibitor therapy discontinuation for chronic myelogenous leukemia to achieve clinical cure: current status and future perspectives

Takashi Kumagai (Deparment of Hematology, Ome Municipal General Hospital, Japan)